US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.87

-0.2800-1.11%

Post-market: 24.870.00000.00%19:30 EDT

Volume:23.02K

Turnover:576.09K

Market Cap:57.70M

PE:- -

High:25.58

Open:25.53

Low:24.67

Close:25.15

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:0.72

T/O Rate:0.99%

Dividend:1.71

Dividend Rate:6.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Compass Pathways PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Compass Pathways Publishes Investor Presentation on Comp360 Psilocybin Program, FDA Filing Progress and Launch Plans

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate

Benzinga Earnings

Compass Pathways Q2 EPS USD -1.88

THOMSON REUTERS

Compass Pathways Q2 Operating Expenses USD 52.372 Million

THOMSON REUTERS

Press Release: Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

Heavy Rare Earths plans major equity raising via pro rata offer and placement

Heavy Rare Earths Limited launches $2.0m capital raising to fund drilling and project review

Relmada Therapeutics Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview

Iceni Gold Plans Share and Option Issue to Bolster Exploration Funding

Kuniko plans equity and option issue to bolster capital base

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72

Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award

Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview

Patagonia Lithium shareholders back capital raising and option changes at 2026 meeting

InSilico Medicine Wins China IND for AI-Designed Parkinson’s Drug

Yari Resources Plans Major Share and Option Placement to Expand Capital Base

Red Sky ramps up Innamincka drilling as capital raisings bolster cash

Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/PSIL/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.87,"timestamp":1789761600000,"preClose":25.15,"halted":0,"volume":23017,"hourTrading":{"tag":"盘后","latestPrice":24.87,"preClose":24.87,"latestTime":"19:30 EDT","volume":13,"amount":323.31,"timestamp":1789774204499,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.011133200795228533,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Market Closed","change":-0.28,"latestTime":"09-18 16:00:00 EDT","open":25.53,"high":25.58,"low":24.67,"amount":576091.019912,"amplitude":0.036183,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":25.15,"sharesOutstanding":1184976,"nav":24.676,"aum":57248825.63,"dividendRate":0.068565,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":25.86,"preClose":25.15,"latestTime":"09:17 EDT","volume":28,"amount":719.9700200000001,"timestamp":1789737431335,"change":0.71,"changeRate":0.028231,"amplitude":0.020278},"postHourTrading":{"tag":"盘后","latestPrice":24.87,"preClose":24.87,"latestTime":"19:30 EDT","volume":13,"amount":323.31,"timestamp":1789774204499,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7196050720575493,"impliedVol":0.3416,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7196050720575493,"shares":2319976,"dividePrice":1.7052,"high":25.58,"amplitude":0.036183,"preClose":25.15,"low":24.67,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.87,"eps":0,"divideRate":0.068565,"volume":23017,"delay":0,"ttmEps":0,"open":25.53,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.7682,"twentyDayClose":25.95,"sixtyDayClose":21.7221},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657540547","title":"Compass Pathways PLC Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540547","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657540547?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:32","pubTimestamp":1785936746,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC reports results for the quarter ended June 30 - Earnings SummaryCompass Pathways PLCCMPS.OQreported a quarterly adjusted loss of $1.88 per share for the quarter ended June 30, low","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N44224E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544828","title":"Compass Pathways Publishes Investor Presentation on Comp360 Psilocybin Program, FDA Filing Progress and Launch Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544828","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544828?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:07","pubTimestamp":1785931637,"startTime":"0","endTime":"0","summary":"Compass Pathways publishes investor presentation on COMP360 psilocybin program, FDA filing progress and launch plansCompass Pathways outlined plans to file a rolling NDA for COMP360 psilocybin in trea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL9WMrTH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657545831","title":"Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657545831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657545831?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:45","pubTimestamp":1785926714,"startTime":"0","endTime":"0","summary":"Compass Pathways' Q2 loss widens on commercial readiness activity costsOverviewUK mental health biotech's Q2 operating income missed analyst estimatesNet loss widened yr/yr, mainly due to non-cash war","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046234339.USD","LU0997586432.USD","LU1670710588.SGD","LU2065170008.USD","LU2237443978.SGD","LU0310799852.SGD","AZN.UK","LU1196032939.SGD","LU1153585028.USD","LU1718418525.SGD","LU1057294990.SGD","LU0432979614.USD","LU1291159041.SGD","LU0096364046.USD","SG9999001176.USD","LU0526926950.USD","LU1863844749.USD","LU0203345920.USD","LU0575583348.USD","LU2539964713.USD","LU1989772923.USD","SGXZ57979304.SGD","LU0306807586.USD","IHE","LU2125154935.USD","BMY","LU1481600234.SGD","LU1880407215.USD","LU0757432116.USD","LU1585245621.USD","03165","LFSC","LIVN","LU2089284900.SGD","BK4007","LU0266013472.USD","LU2596442595.SGD","CMPS","SG9999013999.USD","LU0211326839.USD","LU2065171311.SGD","LU0985481810.HKD","LU2279689827.SGD","LU0321505868.SGD","LU1983299246.USD","ACAD","PSIL","LU1273509221.SGD","FTXH","LU0496365809.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657254330","title":"Compass Pathways Q2 EPS $(1.88) Misses $(0.37) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657254330","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657254330?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:33","pubTimestamp":1785925989,"startTime":"0","endTime":"0","summary":"Compass Pathways (NASDAQ:CMPS) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.37) by 408.11 percent. This is a 358.54 percent decrease over losses of $(0.41) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60941435/compass-pathways-q2-eps-1-88-misses-0-37-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMPS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548774","title":"Compass Pathways Q2 EPS USD -1.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548774?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXD2DKG4:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548002","title":"Compass Pathways Q2 Operating Expenses USD 52.372 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548002","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548002?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLXD2DKG4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657354829","title":"Press Release: Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657354829","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657354829?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:30","pubTimestamp":1785925800,"startTime":"0","endTime":"0","summary":"--  Data from two positive Phase 3 trials demonstrated rapid onset of. effect and durable benefit through at least 6 months, further validating. COMP360's potential to establish a new standard of care in TRD. --  COMP360 has a highly differentiated clinical profile and is expected to. --  Rolling NDA submission and initial review underway and final submission. --  Commercial launch expected in first half of 2027. --  COMP360 expected to fit seamlessly into current treatment. --  Strong cash position of $433 million at the end of second quarter,--  Compass management will host a conference call on August 5 at 8:00 am. options in mental health care -- moving beyond daily or frequent. administration toward an option that could potentially provide strong. efficacy with just a few treatments a year that could be life changing. --  Across two highly statistically significant positive Phase 3 trials,COMP360 is the first classic psychedelic1 to consistently demonstrate. rapid onset, sustained ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4223","PSIL","CMPS","DEA","NPV","BK4194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657951495","title":"Heavy Rare Earths plans major equity raising via pro rata offer and placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657951495","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657951495?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:37","pubTimestamp":1785890250,"startTime":"0","endTime":"0","summary":"Heavy Rare Earths Limited ( ($AU:HRE) ) has issued an announcement. Heavy Rare Earths Limited has lodged details of a proposed capital raising with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-plans-major-equity-raising-via-pro-rata-offer-and-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-plans-major-equity-raising-via-pro-rata-offer-and-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","SETM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657595104","title":"Heavy Rare Earths Limited launches $2.0m capital raising to fund drilling and project review","url":"https://stock-news.laohu8.com/highlight/detail?id=2657595104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657595104?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:37","pubTimestamp":1785890234,"startTime":"0","endTime":"0","summary":"Heavy Rare Earths Limited ( ($AU:HRE) ) just unveiled an update. Heavy Rare Earths Limited has launched a capital raising of up to $2.028 million v...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-limited-launches-2-0m-capital-raising-to-fund-drilling-and-project-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/heavy-rare-earths-limited-launches-2-0m-capital-raising-to-fund-drilling-and-project-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","SETM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657600845","title":"Relmada Therapeutics Inc Expected to Post a Loss of 20 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657600845","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657600845?lang=en_us&edition=fundamental","pubTime":"2026-08-05 06:10","pubTimestamp":1785881405,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc <RLMD.OQ> expected to post a loss of20cents a share - Earnings PreviewRelmada Therapeutics IncRLMD.OQRLMD.Ois expected to  show no change in quarterly revenue when it reports ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4413EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588643","title":"Iceni Gold Plans Share and Option Issue to Bolster Exploration Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588643","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588643?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:24","pubTimestamp":1785799494,"startTime":"0","endTime":"0","summary":"Iceni Gold Ltd. ( ($AU:ICL) ) has issued an update. Iceni Gold Ltd has outlined plans for a new capital raising via a proposed placement or similar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iceni-gold-plans-share-and-option-issue-to-bolster-exploration-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iceni-gold-plans-share-and-option-issue-to-bolster-exploration-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IAU","SGCmain","DUST","NUGT","GCmain","518880","MGCmain","GLD","PSIL","SGUmain","159934","GDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588694","title":"Kuniko plans equity and option issue to bolster capital base","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588694?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:24","pubTimestamp":1785799458,"startTime":"0","endTime":"0","summary":"Kuniko Ltd. ( ($AU:KNI) ) has shared an update. Kuniko Limited has lodged a new Appendix 3B with the ASX outlining a proposed capital raising throu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kuniko-plans-equity-and-option-issue-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kuniko-plans-equity-and-option-issue-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300056","title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300056","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300056?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:10","pubTimestamp":1785798604,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $98,821.72David Joseph Gaffin, EVP and chief legal officer, sold 2,034 ordinary shares on Aug. 3, 2026 at USD 48.58.His direct stake fell t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9zXC08:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","ALKS","MEDX","IBRN","BK4139","FBT","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656019363","title":"Alkermes Amends 8-K to Disclose CEO Blair Jackson Pay Package Including $5 Million Equity Award","url":"https://stock-news.laohu8.com/highlight/detail?id=2656019363","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656019363?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:09","pubTimestamp":1785787780,"startTime":"0","endTime":"0","summary":"Alkermes amends 8-K to disclose CEO Blair Jackson pay package including $5 million equity awardAlkermes amended a Feb. 25 Form 8-K on its CEO succession to add previously undetermined compensation ter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL2dlwWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","PSIL","IBRN","BK4139","MEDX","ALKS","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656537177","title":"Compass Pathways PLC Expected to Post a Loss of 40 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656537177","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656537177?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:11","pubTimestamp":1785762665,"startTime":"0","endTime":"0","summary":"Compass Pathways PLC <CMPS.OQ> expected to post a loss of40cents a share - Earnings PreviewCompass Pathways PLCCMPS.OQCMPS.Ois expected to  show no change in quarterly revenue when it reports  results","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4401E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPS","PSIL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656834496","title":"Patagonia Lithium shareholders back capital raising and option changes at 2026 meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2656834496","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656834496?lang=en_us&edition=fundamental","pubTime":"2026-08-03 09:47","pubTimestamp":1785721651,"startTime":"0","endTime":"0","summary":"Patagonia Lithium Limited ( ($AU:PL3) ) just unveiled an update. Patagonia Lithium Ltd has reported that all resolutions put to shareholders at its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/patagonia-lithium-shareholders-back-capital-raising-and-option-changes-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/patagonia-lithium-shareholders-back-capital-raising-and-option-changes-at-2026-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","PSIL","SETM","LIT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656349689","title":"InSilico Medicine Wins China IND for AI-Designed Parkinson’s Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2656349689","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656349689?lang=en_us&edition=fundamental","pubTime":"2026-08-03 08:38","pubTimestamp":1785717492,"startTime":"0","endTime":"0","summary":"The latest announcement is out from InSilico Medicine Cayman TopCo ( ($HK:3696) ). InSilico Medicine has secured investigational new drug approval ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/insilico-medicine-wins-china-ind-for-ai-designed-parkinsons-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/insilico-medicine-wins-china-ind-for-ai-designed-parkinsons-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QTOC","CHAT","ARTY","AGIX","IND","TBXU","VTHR","PSIL","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656465933","title":"Yari Resources Plans Major Share and Option Placement to Expand Capital Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2656465933","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656465933?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:29","pubTimestamp":1785713343,"startTime":"0","endTime":"0","summary":"Consolidated Zinc Limited ( ($AU:YAR) ) has issued an update. Yari Resources has announced a proposed capital raising involving a large placement o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yari-resources-plans-major-share-and-option-placement-to-expand-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yari-resources-plans-major-share-and-option-placement-to-expand-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DBB","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655443848","title":"Red Sky ramps up Innamincka drilling as capital raisings bolster cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2655443848","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655443848?lang=en_us&edition=fundamental","pubTime":"2026-07-30 07:53","pubTimestamp":1785369203,"startTime":"0","endTime":"0","summary":"Red Sky Energy Limited ( ($AU:ROG) ) has provided an announcement. Red Sky Energy has moved from planning into on‑ground activity at the Innamincka...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/red-sky-ramps-up-innamincka-drilling-as-capital-raisings-bolster-cash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/red-sky-ramps-up-innamincka-drilling-as-capital-raisings-bolster-cash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655890242","title":"Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655890242?lang=en_us&edition=fundamental","pubTime":"2026-07-30 01:55","pubTimestamp":1785347731,"startTime":"0","endTime":"0","summary":"Grifols (GRFS) issued the following statement on the EXCELL Phase 3 trial timeline: “We have noted the recent Bloomberg article referring to the EX...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grifols-says-excell-phase-3-trial-timeline-not-new-development-or-a-delay-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grifols-says-excell-phase-3-trial-timeline-not-new-development-or-a-delay-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PSIL","BBC","GRFS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}